-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Protagonist Therapeutics, Maintains $80 Price Target

Benzinga·04/10/2025 16:52:08
Listen to the news
HC Wainwright & Co. analyst Douglas Tsao reiterates Protagonist Therapeutics (NASDAQ:PTGX) with a Buy and maintains $80 price target.